Education
About Us
Working with TipRanks
Follow Us
Beyondspring (BYSI)
:BYSI
BYSI Stock Chart & Stats
$2.09
-$0.09(-5.17%)
At close: 4:00 PM EST
$2.09
-$0.09(-5.17%)
Day’s Range― - ―
52-Week Range$0.98 - $3.44
Previous CloseN/A
Volume3.10K
Average Volume (3M)444.05K
Market Cap
$81.42M
Enterprise Value$72.72M
Total Cash (Recent Filing)$12.62M
Total Debt (Recent Filing)$406.00K
Price to Earnings (P/E)―
Beta0.56
Next Earnings
May 06, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.04
Shares Outstanding41,122,320
10 Day Avg. Volume1,287,520
30 Day Avg. Volume444,046
Financial Highlights & Ratios
PEG Ratio0.12
Price to Book (P/B)-1.97
Price to Sales (P/S)0.00
P/FCF Ratio-3.89
Enterprise Value/Market Cap0.89
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-3.46K
Enterprise Value/Ebitda-9.36
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Beyondspring News
BYSI FAQ
What was Beyondspring’s price range in the past 12 months?
Beyondspring lowest stock price was $0.98 and its highest was $3.44 in the past 12 months.
What is Beyondspring’s market cap?
Beyondspring’s market cap is $81.42M.
When is Beyondspring’s upcoming earnings report date?
Beyondspring’s upcoming earnings report date is May 06, 2026 which is in 138 days.
How were Beyondspring’s earnings last quarter?
Beyondspring released its earnings results on Nov 12, 2025. The company reported -$0.038 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.038.
Is Beyondspring overvalued?
According to Wall Street analysts Beyondspring’s price is currently Overvalued.
Does Beyondspring pay dividends?
Beyondspring does not currently pay dividends.
What is Beyondspring’s EPS estimate?
Beyondspring’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Beyondspring have?
Beyondspring has 41,122,320 shares outstanding.
What happened to Beyondspring’s price movement after its last earnings report?
Beyondspring reported an EPS of -$0.038 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -3.636%.
Which hedge fund is a major shareholder of Beyondspring?
Currently, no hedge funds are holding shares in BYSI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Beyondspring Stock Smart Score
Company Description
Beyondspring
BeyondSpring Inc. (NASDAQ: BYSI) is a global biopharmaceutical company focused on the development and commercialization of innovative cancer therapies. Headquartered in New York City, the company is dedicated to improving clinical outcomes for patients with high unmet medical needs. BeyondSpring's lead asset, Plinabulin, is a first-in-class immune-oncology agent that is being developed as a potential treatment for chemotherapy-induced neutropenia and non-small cell lung cancer. The company's pipeline includes additional oncology assets in various stages of development.
Technical Analysis
Plus Therapeutics
―
X4 Pharmaceuticals
―
ABVC BioPharma
―
Prelude Therapeutics
―
Gain Therapeutics
―
Ownership Overview
22.29% Insiders
1.83% Mutual Funds
10.73% Other Institutional Investors
63.62% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---